The University of North Carolina School of Medicine is a professional school within the University of North Carolina at Chapel Hill. It offers a Doctor of Medicine degree along with combined Doctor of Medicine / Doctor of Philosophy or Doctor of Medicine / Master of Public Health degrees.

During the past decade, University of North Carolina School of Medicine conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 22 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 11 clinical trials were completed. i.e. 68.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of North Carolina School of Medicine" #1 sponsor was "Bristol-Myers Squibb" with 8 trials, followed by "University of North Carolina, Chapel Hill" with 8 trials sponsored, "Abbott" with 5 trials sponsored, "Gilead Sciences" with 3 trials sponsored and "Inovio Pharmaceuticals" with 3 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of North Carolina School of Medicine" #1 collaborator was "University of North Carolina" with 5 trials as a collaborator, "Duke University" with 3 trials as a collaborator, "Johns Hopkins University" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "University of North Carolina School of Medicine" are "HIV Infections" (12 trials), "Breast Cancer" (3 trials), "Crohn's Disease" (3 trials), "Depression" (3 trials) and "Hepatitis C" (3 trials). Many other conditions were trialed in "University of North Carolina School of Medicine" in a lesser frequency.

Most popular intervention types in "University of North Carolina School of Medicine" are "Drug" (64 trials), "Biological" (12 trials), "Device" (9 trials), "Behavioral" (6 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Daclatasvir" (4 trials), "Ribavirin" (3 trials), "Azithromycin" (2 trials) and "CELLECTRA™ 2000" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of North Carolina School of Medicine" are 82 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of North Carolina School of Medicine". undefined are not yet recruiting, 7 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 67 completed trials in University of North Carolina School of Medicine, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University of North Carolina School of Medicine, 10 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 17 trials that are defined as “Not Applicable".